@ISIDEWITHQuestions医保8yrs ago

政府是否应该管控救命药品的价格？

药品福利计划（PBS）消耗占政府医疗保健支出约14％，已涵盖了范围药品大幅增长，支出因为它是在药品价格管制的支持者们1950年首次引入认为，药品制造商提高到价格受益他们的股票的价值和投资小利润在发展和新药物的研究。调控的反对者认为，消费者依赖药物公司开发新的药物和限制价格将阻止新的挽救生命的药物从正在开发中。

▲Reply to this •••+ My feed React Follow

91% 是的	9% 不
87% 是的	6% 不
2% 是的，我们应该有公费医疗和医疗保健	1% 不，限制药品价格也会限制对研发新救命药物的投入
2% 是，政府应该管控所有处方药的定价	1% 不，但应缩短药品专利的期限
	0% 不，政府绝不应该管控私营企业的定价

Historical Results

See how support for each position on “Drug Price Regulation” has changed over time for 243k 澳大利亚 voters.

正在载入数据......

Loading chart...

Historical Importance

See how importance of “Drug Price Regulation” has changed over time for 243k 澳大利亚 voters.

正在载入数据......

Loading chart...

Discussions

Voter guides

Data & analytics

候选人

About

澳大利亚讲中文

iSideWith.com

iSideWith.com is the world’s most popular voting guide for citizens to find information about elections, political parties, candidates, voting districts and popular political issues in their country. We are independent and not affiliated with any investors, shareholders, political parties or interest groups.

电子邮件推特 Facebook的 YouTube Podcast Patreon

I understand that submitting my email address allows iSideWith.com to send me important notifications via email. Read our privacy policy for more information.

© 2024 iSideWith.com. All rights reserved. Use of this site constitutes acceptance of our user agreement and privacy policy. iSideWith.com may earn a portion of sales from products that are purchased through our site as part of our affiliate partnerships with retailers. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of iSideWith.com.